Skip to main content
SpringerLink
Log in

Infections in Immunosuppressed Pediatric Patients

  • Living reference work entry
  • First Online:
Pediatric Surgical Oncology

  • 109 Accesses

Abstract

Infections are an important cause of morbidity and mortality in children undergoing treatment for cancer. Up to two-thirds of toxic deaths during cancer treatment are caused by infections, which are especially lethal during intensive cancer therapy. In immunosuppressed pediatric patients, the etiology of infections ranges from common pathogens infecting their usual hosts to opportunistic microorganisms arising from the normal flora, from the reactivation of past infections, or from the environment. Risk factors that make immunosuppressed children vulnerable to infections include frequent breaches of the natural barriers of the body, alterations in innate and acquired immunity, the presence of foreign bodies, intensive medical care, and malnutrition. Infectious syndromes frequently seen in immunosuppressed children include febrile neutropenia, bacteremias, sepsis and septic shock, respiratory infections, skin and soft tissue infections, and alimentary tract infections. Infections may be caused by fungal, bacterial, viral, or parasitic pathogens, some of which exhibit multidrug resistance. Surgical site infections are potentially serious complications, and preventing these is of the upmost importance. They can be decreased by ensuring optimal preparation of the environment of care and appropriate conduct of the surgical procedures, including timely administration of prophylactic antimicrobials. Providers of care for children with cancer must have an excellent knowledge of the various types of malignancies, the risk factors for infections, and the causative pathogens thereof, together with awareness of the most effective antibiotics, the effects of drugs, and potential drug–drug interactions. This knowledge will enable care providers to manage the treatment of children with infections and cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Li MJ, Chang HH, Yang YL, et al. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: a 16-year tertiary single-institution experience. Pediatr Blood Cancer. 2017;64:e26535.

    Google Scholar 

  2. Howard SC, Metzger ML, Wilimas JA, et al. Childhood cancer epidemiology in low-income countries. Cancer. 2008;112(3):461–72.

    Article  PubMed  Google Scholar 

  3. Gavidia R, Fuentes SL, Vasquez R, et al. Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador. PLoS One. 2012;7(8):e43639.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Khan ZUA, Amin N, Mohammad GAM, Tarmoom S, AlGhar MY, Aldahir AS, AlShahrani D. Prevalence of infectious complications in children with cancer. J Cancer Ther. 2019;10:938–47.

    Article  Google Scholar 

  5. Simon A, Ammann RA, Bode U, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis. 2008;8:70.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Aviles-Robles M, Ojha RP, Gonzalez M, et al. Bloodstream infections and inpatient length of stay among pediatric cancer patients with febrile neutropenia in Mexico City. Am J Infect Control. 2014;42(11):1235–7.

    Article  PubMed  Google Scholar 

  7. Arbune M, Gurau G, Niculet E, et al. Prevalence of antibiotic resistance of ESKAPE pathogens over five years in an infectious diseases hospital from South-East of Romania. Infect Drug Resist. 2021;14:2369–78.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Camacho-Silvas LA, Portillo-Gallo JH, Rivera-Cisneros AE, Sánchez-González JM, Franco-Santillán R, Duque-Rodríguez J, Velo-Méndez G, Ishida-Gutiérrez MC. Clinical factors associated to bacterial resistance at the North of Mexico. Rev Mex Patol Clin Med Lab. 2020;67:205–9.

    Google Scholar 

  9. Chamseddine S, Chmaisse A, Akel I, et al. Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon. PLoS One. 2020;15(9):e0239258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zajac-Spychala O, Kampmeier S, Lehrnbecher T, Groll AH. Infectious complications in paediatric haematopoetic cell transplantation for acute Lymphoblastic Leukemia: current status. Front Pediatr. 2021;9:782530.

    Article  PubMed  Google Scholar 

  11. Czyzewski K, Galazka P, Zalas-Wiecek P, et al. Infectious complications in children with malignant bone tumors: a multicenter nationwide study. Infect Drug Resist. 2019;12:1471–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009;31(9):623–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile Infection in children. JAMA Pediatr. 2013;167(6):567–73.

    Article  PubMed  Google Scholar 

  14. Green KY. Norovirus infection in immunocompromised hosts. Clin Microbiol Infect. 2014;20(8):717–23.

    Article  CAS  PubMed  Google Scholar 

  15. Sebire NJ, Malone M, Shah N, Anderson G, Gaspar HB, Cubitt WD. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J Clin Pathol. 2004;57(9):1001–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Malcolm TR, Chin-Hong PV. Endemic mycoses in immunocompromised hosts. Curr Infect Dis Rep. 2013;15(6):536–43.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Groll AH, Castagnola E, Cesaro S, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15(8):e327–40.

    Article  PubMed  Google Scholar 

  18. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082–94.

    Article  CAS  PubMed  Google Scholar 

  19. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427–31.

    Article  PubMed  Google Scholar 

  20. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7(10):645–57.

    Article  PubMed  Google Scholar 

  21. Demaret P, Pettersen G, Hubert P, Teira P, Emeriaud G. The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit. Ann Intensive Care. 2012;2(1):14.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Loeffen EA, Brinksma A, Miedema KG, de Bock GH, Tissing WJ. Clinical implications of malnutrition in childhood cancer patients–infections and mortality. Support Care Cancer. 2015;23(1):143–50.

    Article  CAS  PubMed  Google Scholar 

  23. Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296–304.

    Article  PubMed  Google Scholar 

  24. Prasad M, Chinnaswamy G, Arora B, Vora T, Hawaldar R, Banavali S. Risk predictors for adverse outcome in pediatric febrile neutropenia: single center experience from a low and middle-income country. Indian J Cancer. 2014;51(4):432–7.

    Article  CAS  PubMed  Google Scholar 

  25. Das A, Trehan A, Oberoi S, Bansal D. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India. Pediatr Blood Cancer. 2017;64:e26333

    Google Scholar 

  26. Badiei Z, Khalesi M, Alami MH, et al. Risk factors associated with life-threatening infections in children with febrile neutropenia: a data mining approach. J Pediatr Hematol Oncol. 2011;33(1):e9–e12.

    Article  PubMed  Google Scholar 

  27. Hartel C, Deuster M, Lehrnbecher T, Schultz C. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer. 2007;49(6):767–73.

    Article  PubMed  Google Scholar 

  28. Oberoi S, Suthar R, Bansal D, Marwaha RK. Febrile neutropenia: outline of management. Indian J Pediatr. 2013;80(2):138–43.

    Article  PubMed  Google Scholar 

  29. Paganini HS, Santolaya ME, Alvarez M, Arana-Rosainz MJ, Bonilla RA, Bonilla A, Caniza M, Carlesse F, Lopez P, Duenas de Chicas L, de Leon T, del Pont JM, Melgar M, Naranjo L, Odio C, Rodriguez M, Scopinaro M. Diagnóstico y tratamiento de la neutropenia febril en niños con cáncer. Consenso de la Sociedad Latinoamericana de Infectología Pediátrica. Rev Chilena Infectol. 2011;28:10–38.

    Article  Google Scholar 

  30. Pizzo PA, Rubin M, Freifeld A, Walsh TJ. The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr. 1991;119(5):679–94.

    Article  CAS  PubMed  Google Scholar 

  31. Lamy B, Roy P, Carret G, Flandrois JP, Delignette-Muller ML. What is the relevance of obtaining multiple blood samples for culture? A comprehensive model to optimize the strategy for diagnosing bacteremia. Clin Infect Dis. 2002;35(7):842–50.

    Article  PubMed  Google Scholar 

  32. Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis. 2011;53(7):697–710.

    Article  PubMed  Google Scholar 

  33. CDC. National Healthcare Safety Network (NHSN), patient safety component manual. CDC. https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf. Published 2022. Accessed 12 Aug 2022.

  34. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.

    Article  CAS  PubMed  Google Scholar 

  35. Raad I, Chaftari AM. Advances in prevention and management of central line-associated bloodstream infections in patients with cancer. Clin Infect Dis. 2014;59(Suppl 5):S340–3.

    Article  CAS  PubMed  Google Scholar 

  36. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ames SG, Davis BS, Angus DC, Carcillo JA, Kahn JM. Hospital variation in risk-adjusted pediatric sepsis mortality. Pediatr Crit Care Med. 2018;19(5):390–6.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Balamuth F, Weiss SL, Neuman MI, et al. Pediatric severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med. 2014;15(9):798–805.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Evans IVR, Phillips GS, Alpern ER, et al. Association between the New York sepsis care mandate and in-hospital mortality for pediatric sepsis. JAMA. 2018;320(4):358–67.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Odetola FO, Gebremariam A, Freed GL. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics. 2007;119(3):487–94.

    Article  PubMed  Google Scholar 

  41. Prout AJ, Talisa VB, Carcillo JA, et al. Children with chronic disease bear the highest burden of pediatric sepsis. J Pediatr. 2018;199:194–199.e191.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Cvetkovic M, Lutman D, Ramnarayan P, Pathan N, Inwald DP, Peters MJ. Timing of death in children referred for intensive care with severe sepsis: implications for interventional studies. Pediatr Crit Care Med. 2015;16(5):410–7.

    Article  PubMed  Google Scholar 

  43. Morin L, Ray S, Wilson C, et al. Refractory septic shock in children: a European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Med. 2016;42(12):1948–57.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Schlapbach LJ, MacLaren G, Festa M, et al. Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med. 2017;43(8):1085–96.

    Article  PubMed  Google Scholar 

  45. Weiss SL, Balamuth F, Hensley J, et al. The epidemiology of hospital death following pediatric severe sepsis: when, why, and how children with sepsis die. Pediatr Crit Care Med. 2017;18(9):823–30.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):e52–e106.

    Article  PubMed  Google Scholar 

  47. Fazekas T, Eickhoff P, Rauch M, et al. Prevalence and clinical course of viral upper respiratory tract infections in immunocompromised pediatric patients with malignancies or after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol. 2012;34(6):442–9.

    Article  PubMed  Google Scholar 

  48. Chellapandian D, Lehrnbecher T, Phillips B, et al. Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol. 2015;33(5):501–9.

    Article  PubMed  Google Scholar 

  49. Maschmeyer G, Carratala J, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015;26(1):21–33.

    Article  CAS  PubMed  Google Scholar 

  50. Moreno-Perez D, Andres Martin A, Tagarro Garcia A, et al. [Community acquired pneumonia in children: outpatient treatment and prevention]. An Pediatr (Barc). 2015;83(6):439.e431–7.

    Google Scholar 

  51. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637–57.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wilke M, Grube R. Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy. Infect Drug Resist. 2013;7:1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Win W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman’s color atlas and textbook of diagnostic microbiology. Philadelphia: Lippincott Williams & Wilkins; 2006.

    Google Scholar 

  54. Cinausero M, Aprile G, Ermacora P, et al. New frontiers in the pathobiology and treatment of cancer regimen-related mucosal injury. Front Pharmacol. 2017;8:354.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Maria OM, Eliopoulos N, Muanza T. Radiation-induced oral mucositis. Front Oncol. 2017;7:89.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61.

    Article  PubMed  Google Scholar 

  57. Levi ME, Eusterman VD. Oral infections and antibiotic therapy. Otolaryngol Clin N Am. 2011;44(1):57–78, v.

    Article  Google Scholar 

  58. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med. 1994;97(4):339–46.

    Article  CAS  PubMed  Google Scholar 

  59. Gorschluter M, Mey U, Strehl J, et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis. 2006;6:35.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer. 1986;57(3):603–9.

    Article  CAS  PubMed  Google Scholar 

  61. Krones E, Hogenauer C. Diarrhea in the immunocompromised patient. Gastroenterol Clin N Am. 2012;41(3):677–701.

    Article  Google Scholar 

  62. Humphries RM, Linscott AJ. Practical guidance for clinical microbiology laboratories: diagnosis of bacterial gastroenteritis. Clin Microbiol Rev. 2015;28(1):3–31.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Mo QH, Wang HB, Dai HR, et al. Rapid and simultaneous detection of three major diarrhea-causing viruses by multiplex real-time nucleic acid sequence-based amplification. Arch Virol. 2015;160(3):719–25.

    Article  CAS  PubMed  Google Scholar 

  64. Pini Prato A, Castagnola E, Micalizzi C, et al. Early diverting colostomy for perianal sepsis in children with acute leukemia. J Pediatr Surg. 2012;47(10):e23–7.

    Article  PubMed  Google Scholar 

  65. Chen CY, Cheng A, Huang SY, et al. Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia. PLoS One. 2013;8(4):e60624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Safdieh JE, Mead PA, Sepkowitz KA, Kiehn TE, Abrey LE. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70(12):943–7.

    Article  CAS  PubMed  Google Scholar 

  67. Swinburne NC, Bansal AG, Aggarwal A, Doshi AH. Neuroimaging in central nervous system infections. Curr Neurol Neurosci Rep. 2017;17(6):49.

    Article  PubMed  Google Scholar 

  68. de Ory F, Avellon A, Echevarria JE, et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol. 2013;85(3):554–62.

    Article  PubMed  Google Scholar 

  69. Posadas E, Fisher J. Pediatric bacterial meningitis: an update on early identification and management. Pediatr Emerg Med Pract. 2018;15(11):1–20.

    PubMed  Google Scholar 

  70. Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70(Suppl 2):3–10.

    Article  PubMed  Google Scholar 

  71. Almogbel GT, Altokhais TI, Alhothali A, Aljasser AS, Al-Qahtani KM, Arab SF, Alsweirki HMH, Albassam A. Risk factors for surgical site infections in pediatric general surgery: a case–control study. J Pediatr Infect Dis. 2021;16(4):160–5.

    Article  Google Scholar 

  72. Bucher BT, Guth RM, Elward AM, et al. Risk factors and outcomes of surgical site infection in children. J Am Coll Surg. 2011;212(6):1033–1038.e1031.

    Article  PubMed  Google Scholar 

  73. Ansari S, Hassan M, Barry HD, et al. Risk factors associated with surgical site infections: a retrospective report from a developing country. Cureus. 2019;11(6):e4801.

    PubMed  PubMed Central  Google Scholar 

  74. Hernaiz-Leonardo JC, Golzarri MF, Cornejo-Juarez P, et al. Microbiology of surgical site infections in patients with cancer: a 7-year review. Am J Infect Control. 2017;45(7):761–6.

    Article  PubMed  Google Scholar 

  75. Rolston KV, Nesher L, Tarrand JT. Current microbiology of surgical site infections in patients with cancer: a retrospective review. Infect Dis Ther. 2014;3(2):245–56.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Warmann SW, Seitz G, Fuchs J. Surgical complications in pediatric surgical oncology. Pediatr Blood Cancer. 2012;59(2):398–404.

    Article  PubMed  Google Scholar 

  77. Averbuch D, Cordonnier C, Livermore DM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013;98(12):1836–47.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

    Article  CAS  PubMed  Google Scholar 

  79. Bodro M, Gudiol C, Garcia-Vidal C, et al. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Support Care Cancer. 2014;22(3):603–10.

    Article  PubMed  Google Scholar 

  80. McNeil JC, Hulten KG, Kaplan SL, Mahoney DH, Mason EO. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013;32(2):124–8.

    Article  PubMed  Google Scholar 

  81. Iwamoto M, Mu Y, Lynfield R, et al. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics. 2013;132(4):e817–24.

    Article  PubMed  Google Scholar 

  82. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32(7):841–50.

    Article  CAS  PubMed  Google Scholar 

  83. Gudiol C, Carratala J. Antibiotic resistance in cancer patients. Expert Rev Anti-Infect Ther. 2014;12(8):1003–16.

    Article  CAS  PubMed  Google Scholar 

  84. Perez F, Adachi J, Bonomo RA. Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clin Infect Dis. 2014;59(Suppl 5):S335–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Martinez ML, Plata-Menchaca EP, Ruiz-Rodriguez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis. 2020;12(3):1007–21.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin. 2018;68(5):340–55.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Fisher BT, Robinson PD, Lehrnbecher T, et al. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review. J Pediatric Infect Dis Soc. 2018;7(3):191–8.

    Article  PubMed  Google Scholar 

  88. Cornely OA, Bohme A, Reichert D, et al. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis. J Antimicrob Chemother. 2008;61(4):939–46.

    Article  CAS  PubMed  Google Scholar 

  89. Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer. 2001;92(6):1349–53.

    Article  CAS  PubMed  Google Scholar 

  90. Hector RF, Laniado-Laborin R. Coccidioidomycosis – a fungal disease of the Americas. PLoS Med. 2005;2(1):e2.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J. 2006;25(7):634–9.

    Article  PubMed  Google Scholar 

  92. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532–9.

    Article  CAS  PubMed  Google Scholar 

  93. Dornbusch HJ, Groll A, Walsh TJ. Diagnosis of invasive fungal infections in immunocompromised children. Clin Microbiol Infect. 2010;16(9):1328–34.

    Article  CAS  PubMed  Google Scholar 

  94. Hayden R, Pounds S, Knapp K, et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J. 2008;27(9):815–9.

    Article  PubMed  PubMed Central  Google Scholar 

  95. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–21.

    Article  PubMed  Google Scholar 

  96. Ruhnke M, Bohme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology–guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol. 2012;23(4):823–33.

    Article  CAS  PubMed  Google Scholar 

  97. Larsen GY, Mecham N, Greenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics. 2011;127(6):e1585–92.

    Article  PubMed  Google Scholar 

  98. Munoz A, Gonzalez-Vicent M, Badell I, Diaz de Heredia C, Martinez A, Maldonado MS. Mycobacterial diseases in pediatric hematopoietic SCT recipients. Bone Marrow Transplant. 2011;46(5):766–8.

    Article  CAS  PubMed  Google Scholar 

  99. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367(4):348–61.

    Article  CAS  PubMed  Google Scholar 

  100. Tadmori I, Benmiloud S, Habibi M, Hida M. Active tuberculosis in children receiving chemotherapy. Open J Pediatrics. 2022;12:75–80.

    Article  Google Scholar 

  101. de la Camara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant. 2000;26(3):291–8.

    Article  PubMed  Google Scholar 

  102. Starke JR, Smith K. Tuberculosis. In: Feigin and Cherry’s textbook of pediatric infectious diseases, 7th ed. Saunders; Philadelphia, PA, 2013.

    Google Scholar 

  103. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis. 2010;50(Suppl 3):S184–94.

    Article  PubMed  Google Scholar 

  104. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis. 2008;8(8):498–510.

    Article  PubMed  Google Scholar 

  105. Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014;383(9928):1572–9.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495–505.

    Article  PubMed  PubMed Central  Google Scholar 

  107. van de Loo K, Balzer S, MacKenzie CR, et al. Lymphnode tuberculosis in a 4-year-old boy with relapsed ganglioneuroblastoma: a case report. BMC Infect Dis. 2018;18(1):105.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38(10):1428–39.

    Article  PubMed  Google Scholar 

  109. Apiwattankul N, Flynn PM, Hayden RT, Adderson EE. Infections caused by rapidly growing Mycobacteria spp in children and adolescents with cancer. J Pediatric Infect Dis Soc. 2015;4(2):104–13.

    Article  PubMed  Google Scholar 

  110. Lindblom A, Bhadri V, Soderhall S, et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol. 2010;47(3):234–7.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Soudani N, Caniza MA, Assaf-Casals A, et al. Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients. J Med Virol. 2019;91(7):1191–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Caniza MA, Hunger SP, Schrauder A, et al. The controversy of varicella vaccination in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;58(1):12–6.

    Article  PubMed  Google Scholar 

  113. Lauten M, Guttel C, Hartel C, Erdlenbruch B. Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia. Klin Padiatr. 2014;226(3):188–9.

    CAS  PubMed  Google Scholar 

  114. Chen YK, Hou HA, Chow JM, Chen YC, Hsueh PR, Tien HF. The impact of oral herpes simplex virus infection and candidiasis on chemotherapy-induced oral mucositis among patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 2011;30(6):753–9.

    Article  CAS  PubMed  Google Scholar 

  115. Bateman CM, Kesson A, Powys M, Wong M, Blyth E. Cytomegalovirus infections in children with primary and secondary immune deficiencies. Viruses. 2021;13(10):2001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. de Pagter PJ, Schuurman R, Meijer E, van Baarle D, Sanders EA, Boelens JJ. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2008;43(4):361–6.

    Article  PubMed  Google Scholar 

  117. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;59(Suppl 5):S344–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Pio L, Avanzini S, Paraboschi I, et al. Antibiotic prophylaxis in children undergoing abdominal surgery for neoplastic diseases. Infez Med. 2018;26(2):122–5.

    PubMed  Google Scholar 

  119. Perez JMB, Garriga XG. Infecciones Quirurgicas. 2016; Aran Ediciones, Madrid, Spain.

    Google Scholar 

  120. Ling ML, Apisarnthanarak A, Abbas A, et al. APSIC guidelines for the prevention of surgical site infections. Antimicrob Resist Infect Control. 2019;8:174.

    Article  PubMed  PubMed Central  Google Scholar 

  121. International Society for Infectious Diseases. Guide to Infection Control in the Healthcare Setting. 2018. In https://isid.org/guide/. Accessed on 28 Apr 2023.

  122. World Health Organization. Global guidelines for the prevention of surgical site infection. Geneva: World Health Organization; 2018. Licence: CCBY-NC-SA 3.OIGO.

    Google Scholar 

  123. Lehrnbecher T, Fisher BT, Phillips B, et al. Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis. 2020;71(1):226–36.

    Article  CAS  PubMed  Google Scholar 

  124. Thom KA, Kleinberg M, Roghmann MC. Infection prevention in the cancer center. Clin Infect Dis. 2013;57(4):579–85.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Moulik NR, Mandal P, Chandra J, et al. Immunization of children with cancer in India treated with chemotherapy – consensus guideline from the pediatric hematology-oncology chapter and the Advisory Committee on Vaccination and Immunization Practices of the Indian Academy of Pediatrics. Indian Pediatr. 2019;56(12):1041–8.

    Article  PubMed  Google Scholar 

  126. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18.

    Article  PubMed  Google Scholar 

  127. Vacunas C-CAD. Manual de Vacunas en Linea de la AEP. Asociacion Espanola de Pediatria. https://vacunasaep.org/documentos/manual/cap-14. Published 2022. Updated February, 2022. Accessed 28 June 2022.

  128. Martinon-Torres F. Pediatric vaccination against COVID-19 and despite COVID-19. An Pediatr (Engl Ed). 2022;96(1):4–7.

    PubMed  Google Scholar 

  129. Pediatrics AAO. Red Book 2018: report of the committee on infectious diseases. 31st ed. American Academy of Pediatrics; Itasca, IL; 2018.

    Google Scholar 

  130. Caniza MAM, Chang Cojulun A. Infecciones en el paciente pediátrico con cáncer. In: LLA ML, Sevilla Navarro J, editors. Hematologia y Oncologia Pediatricas. 3rd ed. Ergón Creación, S.A; Madrid, Spain; 2015.

    Google Scholar 

  131. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 9th ed. Elsevier; Philadelphia, PA; 2021.

    Google Scholar 

  132. WHO. Recommendations for interrupted or delay routine immunization – summary of WHO position papers. https://cdn.who.int/media/docs/default-source/immunization/immunization_schedules/immunization-routine-table3.pdf?sfvrsn=f549aec8_10&download=true. Published 2021. Accessed 10 Aug 2022.

  133. Posfay-Barbe K, Halasa N. Vaccination issues for transplantation and chemotherapy. In: Pediatric transplant and oncology infectious diseases, 1st ed. Philadelphia: Elsevier; 2021. p. 63–70.

    Google Scholar 

  134. Valentine SL, Bembea MM, Muszynski JA, et al. Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018;19(9):884–98.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Topjian AA, Raymond TT, Atkins D, et al. Part 4: pediatric basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16_Suppl_2):S469–523.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SOLCA sede Quito, Quito, Ecuador

    Joanna Jennia Acebo

  2. Tata Medical Center, Kolkata, India

    Parthasarathi Bhattacharyya

  3. Hospital Civil “Dr. Juan I. Menchaca”, Guadalajara, Mexico

    Griselda Escobedo-Melendez

  4. Instituto Nacional de Pediatria, Mexico City, Mexico

    Hilda Hernandez

  5. National Cancer Institute – Cairo University / Children’s Cancer Hospital Egypt, Cairo, Egypt

    Reham Abdelaziz Khedr

  6. St. Jude Children’s Research Hospital, Memphis, TN, USA

    Miguela A. Caniza

Authors
  1. Joanna Jennia Acebo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Parthasarathi Bhattacharyya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Griselda Escobedo-Melendez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hilda Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Reham Abdelaziz Khedr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miguela A. Caniza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miguela A. Caniza .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Kokila Lakhoo

  2. St. Jude Children's Research Hospital, Memphis, TN, USA

    Abdelhafeez H. Abdelhafeez

  3. Federal University of Sao Paulo, Sao Paulo, Brazil

    Simone Abib

Section Editor information

  1. Pediatric Critical Care, St Jude Children’s Research Hospital, Memphis, USA

    Saad Ghafoor

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Acebo, J.J., Bhattacharyya, P., Escobedo-Melendez, G., Hernandez, H., Khedr, R.A., Caniza, M.A. (2023). Infections in Immunosuppressed Pediatric Patients. In: Lakhoo, K., Abdelhafeez, A.H., Abib, S. (eds) Pediatric Surgical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-71113-9_98-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-71113-9_98-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-71113-9

  • Online ISBN: 978-3-030-71113-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation